TCL Archive Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors July 4, 1997
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive DCBD Board Okays Concept Of Program Announcement To Stimulate Human Monoclonal Antibody Research June 4, 1982